Skip to main content

Table 4 Correlations of ESA dose and ERI with log CD133/Flk1+ EPC, according to ESA type

From: Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients

  ESA dose versus log CD133/Flk1+ EPC ERI versus log CD133/Flk1+ EPC
r p r p
All subjects (n = 101)  − 0.206 0.039  − 0.207 0.037
Epoetin (n = 31)  − 0.176 0.343  − 0.157 0.398
DA (n = 65)  − 0.194 0.122  − 0.213 0.088
CERA (n = 5)  − 0.300 0.624  − 0.600 0.285
  1. Correlations of ESA dose and ERI with log CD133/Flk1+ EPC were analyzed by Spearman’s method. P values in bold indicate statistical significance
  2. DA, darbepoetin alpha; CERA, continuous erythropoietin receptor activator